NCT04164862

Brief Summary

Establishment of venousaccess in the age group ≤12 months can be difficult and associated with repetitive punctures . Numerous techniques to facilitate peripheral venous puncture have been described such as local warming, epidermal nitrogycerine, translumination, and venous cutdown . Ultrasound guidance is reported to facilitate peripheral venous catheterisation in children and to have advantages over blind techniques, especially for challenging veins . Also The AccuVein AV400 device which detects the haemoglobin in the vessels by red and infrared light reflection and shows a vasculature map. AccuVein AV400 device (AV400) improves the success rate of intravenous cannulation in pediatric patients . Most peripheral veins in infants are too superficial and too small for direct visualization. A promising alternative approach could be the great saphenous vein (GSV) at the level of the medial malleolus due to the adequate diameter and the relatively deep position relative to the skin.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 15, 2019

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

November 15, 2019

Status Verified

November 1, 2019

Enrollment Period

3 months

First QC Date

November 5, 2019

Last Update Submit

November 13, 2019

Conditions

Keywords

AccuVein AV400 deviceultrasound-guided cannulation

Outcome Measures

Primary Outcomes (1)

  • the time to successful placement of catheters

    the time to successful placement of catheters

    "Through operation completion, average of 2 hours"

Secondary Outcomes (2)

  • the number of attempts

    "Through operation completion, average of 2 hours"

  • , technique-related pain, occurrence of movements, and occurrence of complications .

    "Through operation completion, average of 2 hours"

Study Arms (2)

use ACCUVEIN AV400

ACTIVE COMPARATOR

Device to facilitate cannulation of the great saphenous vein at the ankle in infants

Device: AccuVein AV400 Device Versus Ultrasound-guided Cannulation

ULTRASOUND GUIDED CANNULATION

ACTIVE COMPARATOR

Ultrasound cannulation of the great saphenous vein in infants

Device: AccuVein AV400 Device Versus Ultrasound-guided Cannulation

Interventions

Accuvein AV400 device versus Ultrasound guided cannulation

ULTRASOUND GUIDED CANNULATIONuse ACCUVEIN AV400

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Infants' ≤12 months
  • ASA physical status I and II
  • undergoing elective surgery
  • with no visible veins at the dorsum of the hands or feet

You may not qualify if:

  • REFUSAL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehab A.Zayed

Alexandria, 000000, Egypt

Location

Study Officials

  • Rehab Zayed, Ass.Prof.

    Alexandria University

    PRINCIPAL INVESTIGATOR
  • yasser Osman, Ass. Prof.

    Alexandria University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Aneasthesia

Study Record Dates

First Submitted

November 5, 2019

First Posted

November 15, 2019

Study Start

September 1, 2019

Primary Completion

December 1, 2019

Study Completion

January 1, 2020

Last Updated

November 15, 2019

Record last verified: 2019-11

Locations